Home Exercise for Individuals With Neurodegenerative Disease

Status Recruiting

Clinical Trial Summary

The primary goal of this study is to address the need for targeted therapeutic interventions for impairments that impact walking in related neurodegenerative diseases.

Clinical Trial Description

This study will inform clinicians in quantitatively assessing baseline disease severity, selectively applying the appropriate exercise to the disease pathology, and measuring efficacy of the exercise intervention. As part of this overall goal, the aims are to: A. Determine feasibility of remotely supervised exercise programs. B. Optimize remote outcome measures for clinical monitoring and towards future clinical trials. C. Measure changes in balance and walking post intervention. ;

Study Design

Related Conditions & MeSH terms

Adrenoleukodystrophy
Adrenomyeloneuropathy
Ataxia
Cerebellar Ataxia
LBSL
Leukodystrophy
Leukoencephalopathies
Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation
Neurodegenerative Diseases

Clinical Trial Details

NCT number	NCT05443906
Study type	Interventional
Source	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Contact	Dandre Amos, BS
Phone	443-923-2769
Email	amosd@kennedykrieger.org
Status	Recruiting
Phase	N/A
Start date	February 13, 2023
Completion date	July 30, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05538455` - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases	N/A
Completed	`NCT05788133` - The Role of Humanoid Robot in Neuropsychological Assessment and Cognitive Training.	N/A
Completed	`NCT05080777` - Pilot Pragmatic Clinical Trial to Embed Tele-Savvy Into Health Care Systems	N/A
Completed	`NCT03295786` - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease	Phase 1/Phase 2
Recruiting	`NCT04265482` - Community-based Cohort of Functional Decline in Subjective Cognitive Complaint Elderly
Not yet recruiting	`NCT02222779` - Quantification of Transition Metals	N/A
Recruiting	`NCT01291550` - Electronic Nose for Diagnosis of Neurodegenerative Diseases Via Breath Samples	N/A
Completed	`NCT01450891` - Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease	N/A
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Recruiting	`NCT06148233` - CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging	N/A
Completed	`NCT03538522` - A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831	Phase 2
Completed	`NCT06251830` - Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?
Recruiting	`NCT04472130` - Neurodegenerative Diseases Registry
Completed	`NCT03353207` - Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for Neurodegeneration
Completed	`NCT05095870` - Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
Recruiting	`NCT05784090` - Correlation Between Melatonin Levels in Different Biological Fluids
Completed	`NCT02108769` - Yogic Breathing Changes Salivary Components	N/A
Recruiting	`NCT05508789` - A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)	Phase 3
Recruiting	`NCT05235802` - Long-term Follow-up in Severe Traumatic Brain Injury
Recruiting	`NCT04820881` - Cerebrovascular Reactivity and Oxygen Metabolism as Markers of Neurodegeneration After Traumatic Brain Injury